Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pneumococcal vaccination in immunosuppressed kidney transplant recipients and end-stage renal disease patients
2016-004123-23Phase 3Completed
- Sponsor
- University Hospital Odense
- Start
- Feb 2017
- Modality
- Vaccines & Immunotherapeutics, Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label trial of pneumococcal 13-valent conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal disease (2 arms), sponsored by University Hospital Odense. Primary endpoint: Change in specific pneumococcal antibody level overall. Started Feb 2017; status: completed.
02
Drugs
pneumococcal 13-valent conjugate vaccine23-valent pneumococcal polysaccharide vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on 2016-004123-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004123-23.